Wall Street brokerages expect that Immunomedics, Inc. (NASDAQ:IMMU) will report ($0.20) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Immunomedics’ earnings, with the lowest EPS estimate coming in at ($0.31) and the highest estimate coming in at ($0.05). Immunomedics reported earnings per share of ($0.25) in the same quarter last year, which would indicate a positive year-over-year growth rate of 20%. The business is scheduled to announce its next earnings results on Wednesday, August 15th.
On....More>>>